Luo Yunxiu

Chief Physician

She specializes in radiation therapy for head and neck tumors (including brain, nasopharynx, oropharynx, hypopharynx, larynx, parotid gland, nasal sinuses, and esophagus), breast cancer, and gastrointestinal malignancies (such as liver cancer, pancreatic cancer, gastric cancer, rectal cancer, cancer of the pancreatic head, and gallbladder cancer). Also proficient in treating urogenital tumors (including cervical cancer, prostate cancer, endometrial cancer, and kidney cancer), pediatric tumors, soft tissue sarcomas, thoracic tumors, and rare tumors. Skilled in integrating advanced multimodal radiation technologies to treat complex and refractory tumors, with extensive experience in the prevention and management of complications from radiotherapy and chemotherapy.

Introduction of the expert

Chief Physician, Doctor of Medicine, and Principal Investigator. Graduated from Central South University and received systematic training in radiation therapy at well-known oncology specialty hospitals in Chengdu, Beijing, and Guangzhou.

Medical specialty

She specializes in radiation therapy for head and neck tumors (including brain, nasopharynx, oropharynx, hypopharynx, larynx, parotid gland, nasal sinuses, and esophagus), breast cancer, and gastrointestinal malignancies (such as liver cancer, pancreatic cancer, gastric cancer, rectal cancer, cancer of the pancreatic head, and gallbladder cancer). Also proficient in treating urogenital tumors (including cervical cancer, prostate cancer, endometrial cancer, and kidney cancer), pediatric tumors, soft tissue sarcomas, thoracic tumors, and rare tumors. Skilled in integrating advanced multimodal radiation technologies to treat complex and refractory tumors, with extensive experience in the prevention and management of complications from radiotherapy and chemotherapy.

Direction of scientific research

Generation and development of malignant tumors, radiation therapy and comprehensive treatment of tumors, multimodal radiotherapy for complex and refractory tumors.

Academic association appointment

Member of the Second Committee of Tumor Support Therapy Professional Committee of Chinese Anti-Cancer Association 
Member of the Third Session of Radiotherapy Equipment Technology Branch of China Medical Equipment Association 
Standing Member of the Seventh Committee of Radiation Oncology Therapeutics Branch of Hainan Provincial Medical Association  
Member of Lung Cancer Professional Committee of Hainan Cancer Prevention and Treatment Association 
Vice Chairman of the MDT Professional Committee of Hainan Cancer Prevention and Treatment Association 
Standing member of the Fertility Preservation Professional Committee of the Maternal and Child Health Association of Hainan Province 
Member of the First Professional Committee of Integrated Rehabilitation of Nasopharyngeal cancer of the Chinese Anti-Cancer Association 
Member of the Expert Committee of the Special Skills Training Program for Precision Radiotherapy for Tumors of the Talent Exchange Service Center of the National Health and Wellness Commission (in the direction of target-area outlining) 
Member of Expert Committee of Medical Quality Control Center for Radiotherapy Specialties in Hainan Province (2023.06-2024.12) 

Papers and works

I. Proteomics analysis of G protein-coupled receptor kinase 4-inhibited cellular growth of HEK293 cells. J Proteomics. 2019; 207:103445。

II. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database,Clin Transl Oncol,2021,7。

III. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma,Int J Gen Med,2021,14: 9247—9260。

IV. Myoepithelial carcinoma of major salivary glands: Analysis ofpopulation-based clinicopathologic and prognostic features,Translational oncology  20 (2022) 101410。